We speak to Peter Nijhuis, Division Head Myopia Management Business Division at Menicon about the Menicon Bloom comprehensive system for myopia management with contact lenses, and about three years of experience in the Netherlands with this landmark system.
The evolution of soft contact lens design from myopia control has come from presbyopia designs to a variety of options today. The newest design is concentric annular zones with noncoaxial relative plus power, called RingBoost technology. The aim is to deliver a high level of relative plus power for increased myopia control efficacy with minimal visual impact – learn more here.
We speak to these leading clinical researchers on the science behind the MiSight® 1 day contact lenses and how the findings of this study can be translated into clinical practice. Both Professor Debbie Jones and Professor Nicola Logan were investigators in the MiSight 1 day clinical trial, which is the longest-running soft contact lens study involving children.
We asked renowned myopia scientist and educator Professor Mark Bullimore about his paper on this topic, which clearly outlines that the benefits outweigh the risks with myopia control. Learn about why this analysis was explored, an overview of the paper and the take-home message for clinical practice, especially for childhood contact lens wear.
The MiSight 1 day clinical trial is the longest-running soft contact lens study among children, and is now reporting seven-year data. With questions explored including efficacy, cross over from control group to treatment and discontinuation, here’s some of what we’ve learnt along the way.
In this Q&A Interview, Optometrist Elizabeth Lumb reflects on the evolution of myopia management in the past five years through two ‘lenses’: as CooperVision’s Director of Global Professional Affairs, Myopia Management, and through the very personal experience of her now 12-year-old niece, Maddy.
Dr Carolyn Lederman, ophthalmologist from the United States, explains how she prescribes and manages myopia patients with the NaturalVue Multifocal 1 Day contact lens in her practice.
A dose-response is where an increasing amount of a medication or intervention is correlated with a better clinical outcome. When it comes to myopia control, we investigate the evidence for a dose-response with spectacle, contact lens, atropine and outdoor time interventions.
Extended depth of focus (EDOF) designs in soft contact lenses are employed for presbyopia correction as well as myopia control. This article explores differences between contact lens designs which could be termed ‘multifocal’, and how this could factor into clinical outcomes.
Myopia controlling contact lenses offer numerous benefits for children. How can you select the most appropriate option, specific to the individual child and their family? Explore these key questions in clinical communication to learn more.
